Keysight Technologies (KEYS) Is Up 8.0% After Unveiling Quantum System Analysis Tool for Engineers

  • In October 2025, Keysight Technologies introduced Quantum System Analysis, a new Electronic Design Automation solution that enables quantum engineers to simulate and optimize quantum systems at the system level, expanding their quantum EDA portfolio.
  • This launch directly addresses industry-wide challenges in system-level quantum design and comes shortly after the Nobel Prize recognized advances in superconducting quantum circuits, an area targeted by Keysight's latest platform.
  • We'll examine how the introduction of system-level quantum simulation capabilities shapes Keysight's investment thesis and growth trajectory.

Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

Advertisement

Keysight Technologies Investment Narrative Recap

For investors considering Keysight Technologies, the core thesis rests on sustained demand for advanced test and measurement solutions driven by accelerating AI adoption, government R&D priorities, and growth in quantum and semiconductor markets. The recent launch of Quantum System Analysis expands Keysight’s position in quantum design and simulation, but does not directly alter the biggest near-term catalyst, AI infrastructure investment, or the current headwind from new tariffs that could pressure margins if cost mitigation falls short.

Of recent announcements, the Quantum System Analysis release is most pertinent, as it showcases Keysight’s investment in innovative quantum EDA tools that serve high-growth R&D sectors. This supports the catalyst of capturing long-term value in emerging quantum computing and advanced semiconductor fields, further diversifying revenue streams beyond traditional hardware and software.

Conversely, investors should be aware that if mitigation measures for rising tariffs are less effective than planned, this could...

Read the full narrative on Keysight Technologies (it's free!)

Keysight Technologies is projected to reach $6.3 billion in revenue and $1.2 billion in earnings by 2028. This is based on analysts' assumptions of 6.5% annual revenue growth and a $656 million increase in earnings from the current $544 million.

Uncover how Keysight Technologies' forecasts yield a $187.60 fair value, a 3% upside to its current price.

Exploring Other Perspectives

KEYS Community Fair Values as at Nov 2025
KEYS Community Fair Values as at Nov 2025

Simply Wall St Community members submitted five fair value estimates for Keysight, ranging from US$141.32 to US$190.01 per share. While views differ, many point to the current tariff-driven cost risk potentially affecting near-term earnings and the company’s profit profile, encouraging you to compare multiple opinions before taking a position.

Explore 5 other fair value estimates on Keysight Technologies - why the stock might be worth as much as $190.01!

Build Your Own Keysight Technologies Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Keysight Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:KEYS

Keysight Technologies

Provides electronic design and test solutions worldwide.

Flawless balance sheet with proven track record.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2554.7% undervalued
110 users have followed this narrative
0 users have commented on this narrative
24 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
213 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
20 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
26 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

DI
divine_4y1uv
AIIO logo
divine_4y1uv on Robo.ai ·

Robo.ai Appoints Former INTERPOL President H.E. Dr. Ahmed Naser Al-Raisi as Chairman of Its Subsidiary Alif Holding

Fair Value:US$0.0027108.0k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
PRCT logo
Betsareoff on PROCEPT BioRobotics ·

PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin

Fair Value:US$25.2629.2% undervalued
4 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
JO
HIMS logo
jorgevalverde2366 on Hims & Hers Health ·

A Digital Healthcare Company Leader

Fair Value:US$6863.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0